8-K/A: Lite Strategy Amends CEO Stock Option Grant Details

Lite Strategy, Inc. filed an 8-K/A to correct the number of stock options granted to CEO Justin J. File and detail a new replacement grant.

Summary

• Lite Strategy, Inc. (LITS) filed an amendment (Form 8-K/A) to its Current Report on Form 8-K filed on November 18, 2025.
• The amendment corrects the number of common stock shares issuable upon exercise of stock options granted to CEO Justin J. File.
• The original Form 8-K erroneously reported a grant of options to purchase 635,000 shares.
• The actual number of shares from the options granted on November 14, 2025, was 180,000 shares.
• On November 20, 2025, the Board approved a grant of 'Replacement Options' to Mr. File for 455,000 shares of Common Stock.
• The exercise price for the Replacement Options is $2.02 per share, which is the greater of the closing price on November 20, 2025 ($1.70) and the exercise price of the original options ($2.02).
• The Replacement Options vest on the same schedule as the original 180,000 options.
• The Replacement Options are contingent upon stockholder approval of a new omnibus equity plan (the 'New Omnibus Plan') at the annual meeting for fiscal year 2026; if not approved, these options will be cancelled.

Sentiment

Score: 6

Explanation: The filing is primarily a correction of an administrative error regarding executive compensation. While the initial error is a minor negative, the transparent correction and the fact that the options' exercise price is above the current market price are slightly positive, leading to a neutral-to-slightly-positive sentiment.

Positives

• The company is transparently correcting an error in a previous filing, demonstrating good corporate governance.
• The exercise price for both the original and replacement options is $2.02, which is above the closing market price of $1.70 on November 20, 2025, meaning the stock must appreciate for the options to be in-the-money.

Negatives

• The initial error in reporting CEO compensation details could indicate internal administrative oversight.
• The grant of 455,000 Replacement Options is contingent on future stockholder approval of a new equity plan, introducing an element of uncertainty regarding the CEO's full intended compensation package.

Risks

• The 455,000 Replacement Options granted to CEO Justin J. File are contingent upon approval by the company's stockholders of a New Omnibus Plan at the annual meeting for fiscal year 2026. If the New Omnibus Plan is not approved, these Replacement Options will be cancelled.

Future Outlook

The future outlook for a portion of CEO Justin J. File's equity compensation is contingent on stockholder approval of a New Omnibus Plan at the fiscal year 2026 annual meeting. If approved, the 455,000 Replacement Options will be valid; otherwise, they will be cancelled.

Management Comments

• The Board of Directors approved the grant of Replacement Options to Justin J. File on November 20, 2025, to correct and finalize his equity compensation package.

Industry Context

This filing is specific to internal corporate governance and executive compensation adjustments, rather than broader industry trends. It reflects a company's process for rectifying administrative errors in executive equity grants.

Comparison to Industry Standards

• The total number of options granted to a CEO (635,000 shares) and the exercise price relative to market price ($2.02 vs. $1.70) would typically be evaluated against peer companies of similar size and stage of development in the technology or software industry. Without specific peer data, a direct comparison is not feasible from this filing alone.
• The requirement for stockholder approval of a new omnibus equity plan is a standard corporate governance practice for significant equity compensation programs, aligning with best practices for shareholder oversight.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of stock options, though the total number of options granted to the CEO remains consistent with the initially reported figure. Shareholder approval of the New Omnibus Plan is required for a significant portion of these options.
• Management (Justin J. File): Clarification and finalization of a significant portion of his equity compensation package, contingent on future shareholder approval.

Next Steps

• Stockholders will vote on the approval of the New Omnibus Plan at the annual meeting for fiscal year 2026.
• The company will continue to operate under the Amended and Restated 2008 Stock Omnibus Equity Compensation Plan until a new plan is approved.

Key Dates

Keywords

Lite Strategy, LITS, stock options, CEO compensation, equity plan, 8-K/A, corporate governance, executive compensation, amendment, Nasdaq